Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2010 | 2 |
2011 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter.
Cancer Gene Ther. 2011 Feb;18(2):123-34. doi: 10.1038/cgt.2010.62. Epub 2010 Oct 8.
Cancer Gene Ther. 2011.
PMID: 20930860
Free PMC article.
Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy.
Cherry T, Longo SL, Tovar-Spinoza Z, Post DE.
Cherry T, et al.
Gene Ther. 2010 Dec;17(12):1430-41. doi: 10.1038/gt.2010.100. Epub 2010 Jul 22.
Gene Ther. 2010.
PMID: 20664541
Free PMC article.
Item in Clipboard
Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4.
Post DE, Sandberg EM, Kyle MM, Devi NS, Brat DJ, Xu Z, Tighiouart M, Van Meir EG.
Post DE, et al.
Cancer Res. 2007 Jul 15;67(14):6872-81. doi: 10.1158/0008-5472.CAN-06-3244.
Cancer Res. 2007.
PMID: 17638898
Free PMC article.
Item in Clipboard
Cite
Cite